Tech Company Financing Transactions
Quotient Therapeutics Funding Round
Quotient Therapeutics, operating out of London, England, raised $50 million from Flagship Pioneering.
Transaction Overview
Company Name
Announced On
11/22/2023
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Undisclosed
Investors
Flagship Pioneering (Lead Investor)
Proceeds Purpose
The company intends to use the funds to advance development of its platform.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
7th Floor 50 Broadway 4
London, England, SW1H 0DB
UK
London, England, SW1H 0DB
UK
Phone
Undisclosed
Website
Email Address
Overview
Quotient Therapeutics engages in transformative medicines made possible with somatic genomics
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Geoffrey Maltzahn
Chief Operating Officer
Scott Hayton
Browse more venture capital transactions:
Prev: 11/22/2023: Nicole Bryl Skincare venture capital transaction
Next: 11/22/2023: Africa Healthcare Network venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs